Synthesis, biological evaluation, and molecular modelling of novel quinoxaline-isoxazole hybrid as anti-hyperglycemic.
Anti-hyperglycemic
Isoxazole
Molecular modelling
Quinoxaline
α-amylase
α-glucosidase
Journal
Computational biology and chemistry
ISSN: 1476-928X
Titre abrégé: Comput Biol Chem
Pays: England
ID NLM: 101157394
Informations de publication
Date de publication:
Oct 2023
Oct 2023
Historique:
received:
09
05
2023
revised:
31
07
2023
accepted:
31
07
2023
medline:
6
9
2023
pubmed:
6
8
2023
entrez:
5
8
2023
Statut:
ppublish
Résumé
In our effort to develop potent anti-hyperglycemic compounds with inhibitory activity against α-amylase and α-glucosidase, a series of novel quinoxaline-isoxazole moieties were synthesized. The novel quinoxaline-isoxazole derivatives were assessed in vitro for their anti-hyperglycemic activities on α-amylase and α-glucosidase inhibitions. The results revealed promising IC
Identifiants
pubmed: 37542847
pii: S1476-9271(23)00129-9
doi: 10.1016/j.compbiolchem.2023.107938
pii:
doi:
Substances chimiques
alpha-Glucosidases
EC 3.2.1.20
Quinoxalines
0
Glycoside Hydrolase Inhibitors
0
alpha-Amylases
EC 3.2.1.1
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
107938Informations de copyright
Copyright © 2023 Elsevier Ltd. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.